Trevi Therapeutics
TRVI
TRVI
36 hedge funds and large institutions have $80.4M invested in Trevi Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
98% less call options, than puts
Call options by funds: $2K | Put options by funds: $88K
Holders
36
Holding in Top 10
–
Calls
$2K
Puts
$88K
Top Buyers
| 1 | +$649K | |
| 2 | +$219K | |
| 3 | +$154K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$111K |
| 5 |
TC
Tejara Capital
London,
United Kingdom
|
+$74.5K |
Top Sellers
| 1 | -$294K | |
| 2 | -$222K | |
| 3 | -$181K | |
| 4 |
Renaissance Technologies
New York
|
-$149K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$37K |